Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.
Press releases published on May 27, 2025

Fasoo Showcases Advanced Data-Centric Security and DSPM Solutions at the Vietnam Security Summit 2025
BETHESDA, MD, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Fasoo, the leader in data-centric security, successfully showcased its latest innovations at the Vietnam Security Summit 2025, held in Ho Chi Minh City on May 23. At Vietnam’s largest …

MarketWise Announces Appointment of Dr. David Eifrig as Chief Executive Officer
BALTIMORE, May 27, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) ("MarketWise" or "the Company"), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for investors …

FARMERS AND MERCHANTS BANCSHARES, INC. PROVIDES UPDATE ON ITS DIVIDEND REINVESTMENT PLAN AND SEMI-ANNUAL DIVIDEND
HAMPSTEAD, Md. , May 27, 2025 (GLOBE NEWSWIRE) -- Farmers and Merchants Bancshares, Inc. (the “Company”), the parent of Farmers and Merchants Bank (the “Bank”), filed a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities …

TeraWulf Acquires Beowulf Electricity & Data, Streamlining Corporate Structure
EASTON, Md., May 27, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, next-generation digital infrastructure primarily powered by zero-carbon energy, announced today the …

GBAC Unveils Quantum Healthcare 2025 Blueprint on Quantum Computing (QC) and AI-Driven Drug Discovery
Board-ready guide charts global Quantum Computing (QC) market and pharma pilots, giving boards actionable governance, security and talent frameworks. WASHINGTON D.C, MD, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Global Board Advisors Corp (GBAC) …

Avalo Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the …